Tolerogenic dendritic cells therapy(University Hospital)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameTolerogenic dendritic cells therapy(University Hospital)
Drug Alias NametolDC
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAntwerp University Hospital
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A